Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 23, 2010, Pages 2141-2144

  Ishihara, Takashi ^a   Nakajima, Naoko ^a   Kadoya, Toshihiko ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Biopharmaceutical; Capture; Protein separation; Purification

Indexed keywords

AFFINITY CHROMATOGRAPHY RESIN; AFFINITY RESINS; BINDING CAPACITIES; BIOPHARMACEUTICAL; CHO CELL; DYNAMIC BINDING CAPACITY; ELUTION PH; FUSION PROTEINS; HUMAN ANTIBODIES; PH GRADIENTS; POLYCLONAL; POLYCLONAL ANTIBODY; PROTEIN SEPARATIONS; TRANSGENIC ANIMALS;

AFFINITY CHROMATOGRAPHY; ANIMALS; CELL CULTURE; MONOCLONAL ANTIBODIES; PROTEINS; PURIFICATION; RESINS;

ANIMAL CELL CULTURE;

HUMAN MONOCLONAL ANTIBODY; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RESIN; DRUG;

ACIDITY; AFFINITY CHROMATOGRAPHY; ANTIGEN BINDING; ARTICLE; CHO CELL; CONTROLLED STUDY; EVALUATION; FEMALE; NONHUMAN; PH; PRIORITY JOURNAL; PURIFICATION; TRANSGENIC ANIMAL; ANIMAL; BOVINAE; CHEMISTRY; CHO CELL LINE; CRICETULUS; DEVICES; EVALUATION STUDY; GEL CHROMATOGRAPHY; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CHO CELLS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; HUMANS; HYDROGEN-ION CONCENTRATION; PHARMACEUTICAL PREPARATIONS; RESINS, SYNTHETIC;

ANIMALIA; BOVINAE;

EID: 77955052367     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.06.003     Document Type: Article

References (19)

1. van Dijk M.A., van de Winkel J.G. Curr. Opin. Chem. Biol. 2001, 5:368.
2. Walsh G. BioPharm 2004, 17:18.
3. Gottschalk U. Biopharm 2005, 18:42.
4. Robil J.M., Kasinathan P., Sullivan E., Kuriowa Y., Tomizuka K., Ishida I. Theriogenology 2003, 59:107.
5. Therapeutic Human Polyclonals Inc. Available from: http://www.polyclonals.com/.
6. Origen Therapeutics Inc. Available from: http://www.origentherapeutics.com/.
7. Prosniak M., Faber M., Hanlon C.A., Rupprecht C.E., Hooper D.C., Dietzschold B. J. Infect. Dis. 2003, 188(1):53.
8. Newcombe C., Newcombe A.R. J. Chromatogr. B 2007, 848:2.
9. Fahrner R.L., Knudsen H.L., Basey C.D., Galan W., Feuerhelm D., Vanderlaan M., Blank G.S. Biotechnol. Genet. Eng. Rev. 2001, 18:301.
10. GE Healthcare Data File 11-0011-65AB.
11. P. Gagnon, Purification Tools for Monoclonal Antibodies, Validated Biosystems, Tucson, AZ, 1996.
12. Ishihara T., Kadoya T., Yoshida H., Tamada T., Yamamoto S. J. Chromatogr. A 2005, 1093:126.
13. GE Healthcare Data File 281-9257-92AA.
14. Ghose S., Allen M., Hubbard B., Brooks C., Cramer S.M. Biotechnol. Bioeng. 2005, 92:665.
15. Hahn R., Schlegel R., Jungbauer A. J. Chromatogr. B 2003, 790:35.
16. Hahn R., Bauerhansl P., Shimahara K., Wizniewski C., Tscheliessnig A., Jungbauer A. J. Chromatogr. A 2005, 1093:98.
17. Hahn R., Shimahara K., Steindl F., Jungbauer A. J. Chromatogr. A 2006, 1102:224.
18. Ghose S., Hubbard B., Cramer S.M. Biotechnol. Bioeng. 2007, 96:768.
19. Teeters M., Benner T., Bezila D., Shen H., Velayudhan A., Alred P. J. Chromatogr. A 2009, 1216:6134.